| Composition and production rate of medical waste from a small producer in Greece. | |
| | |
MedLine Citation:
|
PMID: 20156673 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The objective of this work was to determine the composition and production rate of medical waste from the health care facility of social insurance institute, a small waste producer in Xanthi, Greece. Specifically, produced medical waste from the clinical pathology (medical microbiology) laboratory, the X-ray laboratory and the surgery and injection therapy departments of the health facility was monitored for six working weeks. A total of 240 kg medical solid waste was manually separated and weighed and 330 L of liquid medical waste was measured and classified. The hazardous waste fraction (%w/w) of the medical solid waste was 91.6% for the clinical pathology laboratory, 12.9% for the X-ray laboratory, 24.2% for the surgery departments and 17.6% for the injection therapy department. The infectious waste fraction (%w/w) of the hazardous medical solid waste was 75.6% for the clinical pathology laboratory, 0% for the X-ray laboratory, 100% for the surgery departments and 75.6% for the injection therapy department. The total hazardous medical solid waste production rate was 64+/-15 g/patient/d for the clinical pathology laboratory, 7.2+/-1.6 g/patient/d for the X-ray laboratory, 8.3+/-5.1 g/patient/d for the surgery departments and 24+/-9 g/patient/d for the injection therapy department. Liquid waste was produced by the clinical pathology laboratory (infectious-and-toxic) and the X-ray laboratory (toxic). The production rate for the clinical pathology laboratory was 0.03+/-0.003 L/patient/d and for the X-ray laboratory was 0.06+/-0.006 L/patient/d. Due to the small amount produced, it was suggested that the most suitable management scheme would be to transport the hazardous medical waste, after source-separation, to the Prefectural Hospital of Xanthi to be treated with the hospital waste. Assuming this data is representative of other small medical facilities, medical waste production can be estimated for such facilities distributed around Greece. |
| | |
Authors:
|
Anastasios Graikos; Evangelos Voudrias; Athanasios Papazachariou; Nikolaos Iosifidis; Maria Kalpakidou |
Related Documents
:
|
3193633 - Laboratory and field assessment of molluscicidal activity of b-2 against oncomelania hu... 17214073 - Ethics of clinical pathologist. 17284123 - The art and science of switching antipsychotic medications, part 2. |
Publication Detail:
|
Type: Journal Article Date: 2010-02-13 |
Journal Detail:
|
Title: Waste management (New York, N.Y.) Volume: 30 ISSN: 1879-2456 ISO Abbreviation: Waste Manag Publication Date: 2010 Aug-Sep |
Date Detail:
|
Created Date: 2010-06-11 Completed Date: 2010-08-12 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9884362 Medline TA: Waste Manag Country: United States |
Other Details:
|
Languages: eng Pagination: 1683-9 Citation Subset: IM |
Copyright Information:
|
2010 Elsevier Ltd. All rights reserved. |
Affiliation:
|
Department of Environmental Engineering, Democritus University of Thrace, GR-671 00 Xanthi, Greece. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Greece Hospitals / statistics & numerical data Medical Waste / classification*, statistics & numerical data Medical Waste Disposal* Radioactive Waste / statistics & numerical data |
| Chemical | |
Reg. No./Substance:
|
0/Medical Waste; 0/Medical Waste Disposal; 0/Radioactive Waste |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Surgical Management of Non-small Cell Lung Cancer with Mediastinal Lymphadenopathy.
Next Document: Treating triple-negative breast cancer by a combination of rapamycin and cyclophosphamide: An in viv...